Diazaspiroalkaneone-substituted oxazole derivatives as spleen tyrosine kinase inhibitors
US10053455B2 · kind B2 · utility
0Cited by
12References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 23, 2015 |
| Grant date | Aug 21, 2018 |
| Priority date | — |
| Expiry date | Sep 18, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is concerned with substituted oxazole derivatives that selectively modulate, regulate, and/or inhibit signal transduction mediated by certain native and/or mutant protein kinases implicated in a variety of human and animal diseases such as cell proliferative, metabolic, autoimmune, allergic, and degenerative disorders. In particular, the presently disclosed compounds are Syk inhibitors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.